These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30771173)

  • 1. C. elegans as a Model for Synucleinopathies and Other Neurodegenerative Diseases: Tools and Techniques.
    Koopman M; Seinstra RI; Nollen EAA
    Methods Mol Biol; 2019; 1948():93-112. PubMed ID: 30771173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.
    Harrington AJ; Knight AL; Caldwell GA; Caldwell KA
    Methods; 2011 Mar; 53(3):220-5. PubMed ID: 21195766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
    Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A
    Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases.
    Muñoz-Lobato F; Rodríguez-Palero MJ; Naranjo-Galindo FJ; Shephard F; Gaffney CJ; Szewczyk NJ; Hamamichi S; Caldwell KA; Caldwell GA; Link CD; Miranda-Vizuete A
    Antioxid Redox Signal; 2014 Jan; 20(2):217-35. PubMed ID: 23641861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans.
    Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T
    Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein misfolding and neurodegenerative diseases.
    Uversky VN
    Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not a piece of junk anymore: Pseudogene T04B2.1 performs non-conventional regulatory role and modulates aggregation of α- synuclein and β-amyloid proteins in C. elegans.
    Shukla S; Srividya K; Nazir A
    Biochem Biophys Res Commun; 2021 Feb; 539():8-14. PubMed ID: 33412418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.
    March ZM; Mack KL; Shorter J
    Biophys J; 2019 Apr; 116(8):1380-1385. PubMed ID: 30952364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms.
    Chen X; Burgoyne RD
    BMC Genomics; 2012 Feb; 13():71. PubMed ID: 22333271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.
    Lakso M; Vartiainen S; Moilanen AM; Sirviö J; Thomas JH; Nass R; Blakely RD; Wong G
    J Neurochem; 2003 Jul; 86(1):165-72. PubMed ID: 12807436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the location of the non-local contacts in α-synuclein.
    Bergasa-Caceres F; Rabitz HA
    Biochim Biophys Acta Proteins Proteom; 2018 Dec; 1866(12):1201-1208. PubMed ID: 30278287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases.
    Ma L; Zhao Y; Chen Y; Cheng B; Peng A; Huang K
    Eur J Pharmacol; 2018 Jan; 819():169-180. PubMed ID: 29208474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein propagation: New insights from animal models.
    Dehay B; Vila M; Bezard E; Brundin P; Kordower JH
    Mov Disord; 2016 Feb; 31(2):161-8. PubMed ID: 26347034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
    Wei CC; Chang CH; Liao VH
    Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
    Melki R
    J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.